Form 4: Stryker Corp Executive James Andrew Pierce Reports Stock Option Grant

Group President James Andrew Pierce reports receiving a stock option grant from Stryker Corp.

Summary

• On February 5, 2025, James Andrew Pierce, Group President of Stryker Corp, reported a transaction to the SEC.
• The transaction involved the grant of an employee stock option to purchase 13,458 shares of Stryker's common stock.
• The exercise price of the option is $392.39 per share.
• The options vest in five equal installments, with 20% becoming exercisable on each of the first five anniversaries of the grant date, starting February 5, 2025.
• The options expire on February 4, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a standard executive compensation practice that aligns management interests with shareholder value. The grant itself is a positive indicator of the company's commitment to incentivizing its executives.

Positives

• The stock option grant aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock option grants are a common form of executive compensation in the medical technology industry, used to attract, retain, and incentivize key personnel. This grant is consistent with industry practices for aligning executive compensation with shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the medical device industry.
• Companies like Medtronic, Johnson & Johnson, and Boston Scientific also utilize stock options as part of their long-term incentive plans for executives.
• The vesting schedule of 20% per year over five years is a typical vesting structure observed in similar companies.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes management to improve company performance and increase shareholder value.
• Employees may see the grant as a sign of the company's commitment to its leadership team.

Key Dates

Keywords

Stryker, Stock Option, Form 4, Executive Compensation, James Andrew Pierce, Group President